Combined Pulsed Field Ablation and Left Atrial Appendage Occlusion in a Patient with Persistent Atrial Fibrillation and Adenomyosis-Related Menorrhagia: Case report and One-Year Follow-Up

Clicks: 1
ID: 314575
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #122 of 248 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 248 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Pulsed field ablation (PFA) is an emerging modality for atrial fibrillation management, offering rapid pulmonary vein isolation and the possibility of the left atrial posterior wall ablation. Combining PFA with left atrial appendage occlusion (LAAO) represents a holistic strategy for managing heart rhythm abnormalities and minimizing stroke risk, particularly in patients with high thromboembolic and bleeding risks. Case summary We present a case of a 52-year-old woman with persistent atrial fibrillation, recent percutaneous coronary intervention, and a history of adenomyosis-related menorrhagia, exacerbated by the use of dual antithrombotic therapy. She underwent a single-session PFA and LAAO. The procedure was uncomplicated. At three-month follow-up, imaging confirmed appropriate device placement and complete closure. Anticoagulation was discontinued at three months, and the patient remained asymptomatic at one year follow up while on single antiplatelet therapy. Discussion This case highlights the feasibility and safety of combining PFA and LAAO in a high-risk patient and underscores the potential for broader adoption in selected populations. Larger studies are needed to evaluate long-term outcomes.
Reference Key
openalex_W7162012536 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sophia Alexiou, A Samaras, Georgios Stavropoulos, Apostolos Tzikas, Nikolaos Fragakis
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag353
URL
https://doi.org/10.1093/ehjcr/ytag353
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.